Harrow Inc (NAS:HROW)
$ 40.02 -1.84 (-4.4%) Market Cap: 1.43 Bil Enterprise Value: 1.61 Bil PE Ratio: 0 PB Ratio: 24.55 GF Score: 59/100

Harrow Health Inc at B Riley Neuro & Ophthalmology Conference (Virtual) Transcript

Apr 27, 2022 / 06:00PM GMT
Release Date Price: $6.48 (+2.21%)
Justin Walsh
B. Riley Securities, Inc. - Analyst

My name is Justin Walsh, and I'm a healthcare equity research analyst at B. Riley Securities. For this fireside chat, we are delighted to introduce Harrow Health. We have with us today CEO Mark Baum and CFO Andrew Boll.

Mark, Andrew, thanks for being with us here today. We appreciate you taking the time in the middle of all the exciting things going on at Harrow.

I know that you've grown your company at a 72% CAGR from 2014 to 2021, which is quite impressive. And I'm sure that it hasn't been a straight path to get to this point. But perhaps, it would be helpful for the audience if you could start by telling us where you are today and where you see the business going over the next three to five years.

Mark Baum
Harrow Health, Inc. - CEO and Chairman

Thank you, Justin, and thanks to B. Riley for the audience. So as you know, we started from scratch. We are an eight-year-old startup as a commercial entity. We started with no products, no customers, limited cash, and a drive though to build a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot